Endometrial PolypNCT06826495
Thiol Disulfide Balance and Oxidative Stress Change in Endometrial Polyp Patients
An observational study of Endometrial Polyp and Oxidative Stress, run by Mardin Artuklu University at 1 site in Turkey (Türkiye).
Trial summary
Changes in Thiol Disulfide Balance and Oxidative Stress Mechanisms in Patients with Endometrial Polyps Read more about this study
- Who is it for?
- Ages 20 to 48 years, women only
- Conditions the study is for
- Endometrial Polyp, Oxidative Stress
- Type of treatment
- Injection or infusion
- How many people
- 54 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 2 Jan 2021to 5 Jan 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 48 years
- Women only
- No healthy volunteers
- Adult
Study population: A total of fifty-four participants, aged 20 to 48, took part in the study, including twenty-four women diagnosed with endometrial polyps and thirty women as the control group.
Who may be able to join
- For participants in the control group:
- To be without endometrial polyp
- For the polyp group, they were as follows:
- Individuals experiencing menometrorrhagia
- A body mass index (BMI) of 25 or more
- Hypertension
- Endometrial polyps detected via saline infusion ultrasonography
Who cannot join
- Pregnancy
- Diabetes mellitus
- Pelvic mass
- Malignancy
- The use of Tamoxifen, hormonal contraceptives, or hormone replacement therapy.
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Alanya Training and Research Hospital Gynecology and Obstetrics Department
Antalya
About this study
Changes in Thiol Disulfide Balance and Oxidative Stress Mechanisms in Patients with Endometrial Polyps
- Conditions
- Endometrial Polyp, Oxidative Stress
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| endometrial polyps | Women with endometrial polyp | |
| control group | Participants in the control group were confirmed to be free of endometrial polyps via TVUSG and saline infusion ultrasonography |
What is being measured
The primary outcome is the main question the study is designed to answer.
Oxidative stress markers
Total antioxidant status (μmol Trolox equivalent/ L)
Measured: From January 2021 to January 2022
Oxidative stress markers
Total oxidant status (μmol H2O2 equivalent/L)
Measured: From January 2021 to January 2022
Oxidative stress markers
Oxidative stress index (arbitrary unit)
Measured: From January 2021 to January 2022
Oxidative stress markers
Paraoxonase (U/L)
Measured: From January 2021 to January 2022
Oxidative stress markers
Arylesterase (Ku/l)
Measured: From January 2021 to January 2022
Oxidative stress markers
Total thiol (µmol / L)
Measured: From January 2021 to January 2022
Oxidative stress markers
Native thiol (µmol / L) / alb (g / l)
Measured: From January 2021 to January 2022
Oxidative stress markers
Disulfide (-S-S-) (µmol / L) / alb (g/l)
Measured: From January 2021 to January 2022
Oxidative stress markers
Ischemia-modified albumin (u/L)
Measured: From January 2021 to January 2022
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Feb 2025
- Study start2 Jan 2021
- Primary completion3 Jan 2022
- Study completion5 Jan 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Endometrial PolypStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 54 participants (actual)
Sponsor and investigators
- Lead sponsor
- Mardin Artuklu University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Hasan Basri Savas, Mardin Artuklu University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06826495
- Sponsor's protocol ID
- 10354421-2020/23-8
- Status last verified
- Feb 2025
- First submitted
- 7 Feb 2025
- Last updated
- 14 Feb 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 14 Feb 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Thiol Disulfide Balance and Oxidative Stress Change in Endometrial Polyp Patients
- ClinicalTrials.gov ID
- NCT06826495
- Acronym / sponsor ID
- 10354421-2020/23-8
- Conditions
- Endometrial Polyp, Oxidative Stress
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 54 participants (actual)
- Lead sponsor
- Mardin Artuklu UniversityUniversity, hospital or other
- Study start
- 2 Jan 2021 (actual)
- Primary completion
- 3 Jan 2022 (actual)
- Study completion
- 5 Jan 2022 (actual)
- First posted
- 14 Feb 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Changes in Thiol Disulfide Balance and Oxidative Stress Mechanisms in Patients with Endometrial Polyps
Study design
- Observational model
- Case-control
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| endometrial polyps | – | –Women with endometrial polyp |
| control group | – | –Participants in the control group were confirmed to be free of endometrial polyps via TVUSG and saline infusion ultrasonography |
Who may qualify
- Ages
- 20 to 48 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult
- Study population
- A total of fifty-four participants, aged 20 to 48, took part in the study, including twenty-four women diagnosed with endometrial polyps and thirty women as the control group.
Key inclusion criteria (7 listed)
- To be without endometrial polyp
- Individuals experiencing menometrorrhagia
- A body mass index (BMI) of 25 or more
- Hypertension
- Endometrial polyps detected via saline infusion ultrasonography
Key exclusion criteria (5 listed)
- Pregnancy
- Diabetes mellitus
- Pelvic mass
- Malignancy
- The use of Tamoxifen, hormonal contraceptives, or hormone replacement therapy.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Oxidative stress markers
Time frame: From January 2021 to January 2022
Total antioxidant status (μmol Trolox equivalent/ L)
Oxidative stress markers
Time frame: From January 2021 to January 2022
Total oxidant status (μmol H2O2 equivalent/L)
Oxidative stress markers
Time frame: From January 2021 to January 2022
Oxidative stress index (arbitrary unit)
Oxidative stress markers
Time frame: From January 2021 to January 2022
Paraoxonase (U/L)
Oxidative stress markers
Time frame: From January 2021 to January 2022
Arylesterase (Ku/l)
Oxidative stress markers
Time frame: From January 2021 to January 2022
Total thiol (µmol / L)
Oxidative stress markers
Time frame: From January 2021 to January 2022
Native thiol (µmol / L) / alb (g / l)
Oxidative stress markers
Time frame: From January 2021 to January 2022
Disulfide (-S-S-) (µmol / L) / alb (g/l)
Oxidative stress markers
Time frame: From January 2021 to January 2022
Ischemia-modified albumin (u/L)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Feb 2025.
Related trials for Endometrial Polyp
Not yet recruitingObservational study
Predictors of Successful Office Operative Hysteroscopy Using a Mini-Resectoscope
Retained Products of Conception, Hysteroscopy
RecruitingPhase 1/2
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Cancer, Colorectal Cancer
Not yet recruitingObservational study
Prospective Perioperative Clinical Registry for Women Undergoing Benign Gynecological Surgery
Benign Gynecological Disease, Uterine Fibroids
RecruitingObservational study
Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction
Colorectal Cancer, Endometrial Cancer
Not yet recruiting
Yiwu Cold Knife Technique Versus Electrocision for Multiple Endometrial Polyps
Yiwu Cold Knife Technique for Multiple Endometrial Polyps
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Endometrial Polyp and Oxidative Stress, run by Mardin Artuklu University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 14 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Oxidative stress markers (time frame: From January 2021 to January 2022). The study lists 9 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Feb 2025.